Table 3.
MRI Inflammatory/Damage Scores Categorized by Time Prior to MRI for Remission Criteria
| A) DAS28 Remission < 2.6 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sustained Remission | p-value | ||||||||
| Never in remission | Intermittent remission |
≤ 1yr | > 1yr | ||||||
| N | Median (IQR) / (# zeroes) |
N | Median (IQR) / (# zeroes) |
N | Median (IQR) / (# zeroes) |
N | Median (IQR) / (# zeroes) |
||
| Tenosynovitis | 24 | 6.0 (2.5) / (1) | 39 | 5.5 (3.5) / (0) | 27 | 5.5 (3.5) / (1) | 24 | 4.8 (3.0) / (0) | 0.55 |
| Synovitis | 24 | 3.5 (1.3) / (0) | 39 | 3.5 (1.5) / (0) | 27 | 3.0 (1.5) / (0) | 24 | 3.3 (1.0) / (0) | 0.30 |
| Osteitis | 25 | 1.5 (4.0) / (7) | 39 | 1.0 (2.5) / (10) | 27 | 0.5 (4.0) / (7) | 24 | 1.0 (1.8) / (5) | 0.98 |
| Erosions | 25 | 7.5 (5.0) / (0) | 39 | 7.5 (7.0) / (0) | 27 | 6.5 (9.0) / (0) | 24 | 7.3 (3.8) / (0) | 0.80 |
| Total Inflammatory Score | 24 | 11.0 (6.3) / (0) | 39 | 10.0 (7.5) / (0) | 27 | 10.5 (7.0) / (0) | 24 | 10.0 (4.5) / (0) | 0.71 |
| B) Clinical Disease Activity Index Remission ≤ 2.8 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sustained Remission | p-value | ||||||||
| Never in remission | Intermittent remission |
≤ 1yr | > 1yr | ||||||
| N | Median (IQR) / (# zeroes) |
N | Median (IQR) / (# zeroes) |
N | Median (IQR) / (# zeroes) |
N | Median (IQR) / (# zeroes) |
||
| Tenosynovitis | 39 | 5.5 (3.5) / (1) | 36 | 6.3 (4.0) / (0) | 25 | 5.0 (4.0) / (1) | 15 | 4.5 (2.0) / (0) | 0.11 |
| Synovitis | 39 | 3.5 (1.0) / (0) | 36 | 3.5 (1.0) / (0) | 25 | 3.0 (1.5) / (0) | 15 | 3.0 (1.5) / (0) | 0.13 |
| Osteitis | 40 | 1.8 (5.0) / (9) | 36 | 1.0 (2.8) / (8) | 25 | 0.5 (2.0) / (9) | 15 | 0.5 (1.0) / (4) | 0.13 |
| Erosions | 40 | 8.5 (8.0) / (0) | 36 | 7.8 (4.0) / (0) | 25 | 6.5 (5.0) / (0) | 15 | 7.6 (5.0) / (0) | 0.10 |
| Total Inflammatory Score | 39 | 11.5 (6.5) / (0) | 36 | 11.0 (6.3) / (0) | 25 | 9.0 (4.5) / (0) | 15 | 8.5 (3.0) / (0) | 0.05* |
| C) 2011 ACR/EULAR Boolean-Based Remission Definition | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sustained Remission | p-value | ||||||||
| Never in remission | Intermittent remission |
≤ 1yr | > 1yr | ||||||
| N | Median (IQR) / (# zeroes) |
N | Median (IQR) / (# zeroes) |
N | Median (IQR) / (# zeroes) |
N | Median (IQR) / (# zeroes) |
||
| Tenosynovitis | 60 | 6.0 (3.3) / (1) | 26 | 5.3 (3.5) / (0) | 17 | 4.5 (3.5) / (1) | 8 | 5.3 (1.3) / (0) | 0.41 |
| Synovitis | 60 | 3.5 (1.0) / (0) | 26 | 3.5 (1.0) / (0) | 17 | 2.5 (3.5) / (0) | 8 | 3.0 (0.8) / (0) | 0.03* |
| Osteitis | 61 | 1.5 (3.5) / (14) | 26 | 0.8 (3.5) / (7) | 17 | 1.0 (2.0) / (5) | 8 | 0.5 (0.8) / (2) | 0.41 |
| Erosions | 61 | 8.5 (6.0) / (0) | 26 | 7.0 (7.5) / (0) | 17 | 6.5 (5.0) / (0) | 8 | 6.0 (3.5) / (0) | 0.15 |
| Total Inflammatory Score | 60 | 11.5 (5.8) / (0) | 26 | 9.3 (7.0) / (0) | 17 | 8.5 (4.5) / (0) | 8 | 9.3 (2.8) / (0) | 0.05* |
Asterisk (*) indicates p<0.05